0
     

Report Added
Report already added
Global Antibiotics Market 2022-2028

Global Antibiotics Market 2022-2028

Antibiotics, also known as antibacterials, are used to treat or prevent some types of bacterial infection. They work by killing the bacteria or by making it hard for the bacteria to grow and multiply. According to market research study published by Gen Consulting Company, the global antibiotics market is expected to reach approximately USD 57,435 million, representing a CAGR of 4.3% during the forecast period 2022-2028.

The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global antibiotics market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the antibiotics industry.

This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the drug class, action mechanism, spectrum, route of administration, and region. The global market for antibiotics can be segmented by drug class: aminoglycosides, carbapenems, cephalosporins, fluoroquinolones, macrolides, penicillin, tetracyclines, others. Antibiotics market is further segmented by action mechanism: cell wall inhibitors, DNA inhibitors, protein inhibitors, others. The cell wall inhibitors segment is estimated to account for the largest share of the global antibiotics market. Based on spectrum, the antibiotics market is segmented into: broad-spectrum antibiotics, narrow-spectrum antibiotics. On the basis of route of administration, the antibiotics market also can be divided into: oral, topical, others. In 2021, the oral segment made up the largest share of revenue generated by the antibiotics market. Antibiotics market by region is categorized into: Asia Pacific, Europe, North America, Rest of the World (RoW).

By drug class:
- aminoglycosides
- carbapenems
- cephalosporins
- fluoroquinolones
- macrolides
- penicillin
- tetracyclines
- others

By action mechanism:
- cell wall inhibitors
- DNA inhibitors
- protein inhibitors
- others

By spectrum:
- broad-spectrum antibiotics
- narrow-spectrum antibiotics

By route of administration:
- oral
- topical
- others

By region:
- Asia Pacific
- Europe
- North America
- Rest of the World (RoW)

The market research report covers the analysis of key stake holders of the global antibiotics market. Some of the leading players profiled in the report include Abbott Laboratories, F. Hoffmann-La Roche AG, GlaxoSmithKline plc, Johnson & Johnson, Merck & Co. Inc., Mylan N.V., Novartis International AG, Pfizer Inc., Sanofi S.A., among others.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Historical & Forecast Period
This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.

Scope of the Report
- To analyze and forecast the market size of the global antibiotics market.
- To classify and forecast the global antibiotics market based on drug class, action mechanism, spectrum, route of administration, region.
- To identify drivers and challenges for the global antibiotics market.
- To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global antibiotics market.
- To identify and analyze the profile of leading players operating in the global antibiotics market.

Why Choose This Report
- Gain a reliable outlook of the global antibiotics market forecasts from 2022 to 2028 across scenarios.
- Identify growth segments for investment.
- Stay ahead of competitors through company profiles and market data.
- The market estimate for ease of analysis across scenarios in Excel format.
- Strategy consulting and research support for three months.
- Print authentication provided for the single-user license.
TABLE OF CONTENTS

FIGURES AND TABLES
PART 1. INTRODUCTION
· Report description
· Objectives of the study
· Market segment
· Years considered for the report
· Currency
· Key target audience
PART 2. METHODOLOGY
PART 3. EXECUTIVE SUMMARY
PART 4. MARKET OVERVIEW
· Introduction
· Drivers
· Restraints
· Impact of COVID-19 pandemic
PART 5. MARKET BREAKDOWN BY DRUG CLASS
· Aminoglycosides
· Carbapenems
· Cephalosporins
· Fluoroquinolones
· Macrolides
· Penicillin
· Tetracyclines
· Others
PART 6. MARKET BREAKDOWN BY ACTION MECHANISM
· Cell wall inhibitors
· DNA inhibitors
· Protein inhibitors
· Others
PART 7. MARKET BREAKDOWN BY SPECTRUM
· Broad-spectrum antibiotics
· Narrow-spectrum antibiotics
PART 8. MARKET BREAKDOWN BY ROUTE OF ADMINISTRATION
· Oral
· Topical
· Others
PART 9. MARKET BREAKDOWN BY REGION
· Asia Pacific
· Europe
· North America
· Rest of the World (RoW)
PART 10. KEY COMPANIES
· Abbott Laboratories
· F. Hoffmann-La Roche AG
· GlaxoSmithKline plc
· Johnson & Johnson
· Merck & Co. Inc.
· Mylan N.V.
· Novartis International AG
· Pfizer Inc.
· Sanofi S.A.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
DISCLAIMER

Report Title: Global Antibiotics Market 2022-2028


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW

Related Report

Dental Imaging Systems: Global Markets

Dental Imaging Systems: Global Markets

Telecom operators’ strategies in the health market

Telecom operators’ strategies in the health market

China Bispecific Antibody Market Opportunity & Clinical Trials Insight 2028

China Bispecific Antibody Market Opportunity & Clinical Trials Insight 2028

2022 Vietnam Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 Vietnam Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 Venezuela Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 Venezuela Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 Uruguay Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 Uruguay Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline